Impact of the Distribution to Attending Physicians of a Nominative List of Their Patients Not Participating in the Organised Screening of Colorectal Cancer: Randomised Study Measuring the Impact on Participation
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 48,649
- 试验地点
- 1
- 主要终点
- Patient participation rate to colorectal cancer screening
研究概览
简要总结
Objective : to demonstrate that providing to GPs a list of their patients who are not compliant to colorectal cancer screening will 1) enhance patient participation to screening, and 2) decrease the proportion of cancer diagnosed outside the screening organisation. Design : Randomised controlled study, 3 parallel arms. Enrollment: GPs allocated in the 3 groups of the study will be all GPs 1) from the "Loire-Atlantique and Vendée" geographic area (1300 GPs on average) and 2) who have more than 100 patients in their patient list (based on data provided by the Healthcare Insurance System Services). Patients will be eligible to the study depending on their eligibility to the Faecal Occult Blood Test for colorectal cancer screening : 1) they should be older than 50 and younger than 74; 2) they should not have a personal history of colorectal cancer (or history of adenoma bigger than 1 cm) nor a family history of colorectal cancer. Main outcomes measures : Patient participation to colorectal cancer screening, and number of cancers screened in (versus diagnosed outside) the screening procedure.
详细描述
Background:
Participation rate for colorectal cancer screening in France is 39%. In a Cochrane review, patient participation rates to colorectal cancer screening varies from 30 to 60%. Policy makers usually consider that these participation rates should be higher, based on the premise that the impact of the screening mainly depends on patient participation. In France, patients at average risk of colorectal cancer are eligible to the Faecal Occult Blood Test for colorectal cancer screening if: 1) they are older than 50 and younger than 74; 2) they have no personal history of colorectal cancer (or history of adenoma bigger than 1 cm) and no family history of colorectal cancer.
Objective:
To demonstrate that providing to GPs a list of their patients who are not compliant to colorectal cancer screening will 1) enhance patient participation to screening, and 2) decrease the proportion of cancer diagnosed outside the screening organisation. Design : Randomised controlled study, 3 parallel arms.
Design:
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 25 Years 至 74 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •In this study, the statistical unit is the GP.
- •Inclusion Criteria:
- •GPs allocated in the 3 groups of the study will be all GPs
- •1) from the "Loire-Atlantique and Vendée" geographic area (1300 GPs on average)
- •2) who have more than 100 patients in their patient list (based on data provided by the Healthcare Insurance System Services).
排除标准
- •GPs who have less than 100 patients in their patient list
研究组 & 干预措施
A: nominative list
Providing a list of patients not compliant with CRC sreening
General Practitioners allocated to the intervention group (A) will receive:
- a nominative list of their patients who were not compliant to colorectal cancer screening.
- a document providing general information about colorectal cancer screening
干预措施: Providing a list of patients not compliant with CRC sreening (Other)
A: nominative list
Providing a list of patients not compliant with CRC sreening
General Practitioners allocated to the intervention group (A) will receive:
- a nominative list of their patients who were not compliant to colorectal cancer screening.
- a document providing general information about colorectal cancer screening
干预措施: Providing general information about CRC sreening (Other)
B: general information
Providing general information about CRC screening
General Practitioners allocated to group (B) will receive:
- a document providing general information about colorectal cancer screening (but will not receive the nominative list of patients non compliant to colorectal cancer screening)
干预措施: Providing general information about CRC sreening (Other)
C: usual practice
General Practitioners allocated to group (C) will not receive any information (as in usual practice)
结局指标
主要结局
Patient participation rate to colorectal cancer screening
时间窗: 12 months after starting date of the study
次要结局
- Number of cancers screened in (versus diagnosed outside) the screening procedure.(12 months after starting date of the study)